Search

Your search keyword '"XH Liu"' showing total 2,390 results

Search Constraints

Start Over You searched for: Author "XH Liu" Remove constraint Author: "XH Liu"
2,390 results on '"XH Liu"'

Search Results

51. [Experts consensus on standard items of the cohort construction and quality control of temporomandibular joint diseases (2024)].

52. Selective Generation of Reactive Oxygen Species in Photocatalytic Oxidation by Tuning Porphyrin-Based COFs' Dimensionality.

53. Suicide among patients with oral cancer: A population-based study.

54. Construction of Iron-Scavenging Hydrogel via Thiol-Ene Click Chemistry for Antibiotic-Free Treatment of Bacterial Wound Infection.

55. Effect of Regional Brain Activity Following Repeat Transcranial Magnetic Stimulation in SCA3: A Secondary Analysis of a Randomized Clinical Trial.

56. Retraction Note: The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation.

57. Alcohol intake exacerbates experimental autoimmune prostatitis through gut microbiota driving cholesterol biosynthesis-mediated Th17 differentiation.

58. Research trends of acupressure from 2004 to 2024: A bibliometric and visualization analysis.

59. Lymph node metastasis diagnosis of postoperative OSCC patients by analyzing extracellular vesicles in drainage fluid based on microfluidic isolation.

60. Microsurgical Anatomy of the Common Tendinous Ring and Its Surgical Implications.

61. Advances in small-molecule fluorescent probes for the study of apoptosis.

62. Role of anakinra in patients with ST-elevation myocardial infarction.

64. Prediction of lymphovascular invasion of gastric cancer based on contrast-enhanced computed tomography radiomics.

65. BNT12, a novel hybrid peptide of opioid and neurotensin pharmacophores, produces potent central antinociception with limited side effects.

66. Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway.

67. Generation of an induced pluripotent stem cell line (CSBZZUi001-A) from a female Alzheimer's patient carrying the PSEN1 709 T > C heterozygous mutation.

68. Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment.

69. Novel fabrication of anti-VEGF drug ranibizumab loaded PLGA/PLA co-polymeric nanomicelles for long-acting intraocular delivery in the treatment of age-related macular degeneration therapy.

70. Role of hsa_circ_0007482 in pterygium development: insights into proliferation, apoptosis, and clinical correlations.

71. The role of SEMG1 overexpression in OSCC tumorigenesis and its relation with metabolic molecules.

72. The Correlation between Epicardial Adipose Tissue Thickness Measured by Echocardiography and P-Wave Dispersion and Atrial Fibrillation.

73. Association between metabolic score for insulin resistance and regression to normoglycemia from prediabetes in Chinese adults: A retrospective cohort study.

74. Research progress on physiological processes-based tree-ring width models of Vaganov-Shashkin (VS)and VS-Lite.

75. FAK inhibitors in cancer, a patent review - an update on progress.

76. Apolipoprotein A-IV restrains fat accumulation in skeletal and myocardial muscles by inhibiting lipogenesis and activating PI3K-AKT signalling.

77. A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy.

78. Stereochemical insights into enantioselective antiplasmodial lignanamides from the twigs and leaves of Solanum erianthum.

79. Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021.

80. Broadening Horizons: Exploring the Cathepsin Family as Therapeutic Targets for Alzheimer's Disease.

81. Testicular choriocarcinoma with pelvic and pulmonary metastases: a case report.

82. Skeletal phenotypes and molecular mechanisms in aging mice.

83. Value of improved nursing measures and enhanced nursing management to reduce the occurrence of adverse events in pediatric infusion.

84. Dihydroorotase MoPyr4 is required for development, pathogenicity, and autophagy in rice blast fungus.

85. Molecular engineering of PETase for efficient PET biodegradation.

86. Transformation of A1/A2 Astrocytes Participates in Brain Ischemic Tolerance Induced by Cerebral Ischemic Preconditioning via Inhibiting NDRG2.

87. Spinal Lymphatic Dysfunction Aggravates the Recovery Process After Spinal Cord Injury.

88. Effectiveness and Safety of Shengmai San for Viral Myocarditis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

89. Prospects for the Protective Mechanisms and Compounds of Bufei Huoxue Capsule against COVID-19 Convalescence: Evaluation of Integrating UHPLC-HRMS Analysis and Network Pharmacology Strategy.

90. NMR Studies of the Interactions between Sialyllactoses and the Polysialytransferase Domain for Polysialylation Inhibition.

91. Enantioselective synthesis of chiral amides by carbene insertion into amide N-H bond.

92. Traditional, complementary and integrative medicine for fatigue post COVID-19 infection: A systematic review of randomized controlled trials.

93. Simulation and calibration of radiation monitoring of nuclear power plant containment sump waste liquid.

94. Genome sequences and population genomics reveal climatic adaptation and genomic divergence between two closely related sweetgum species.

95. Traditional Chinese medicine for post-viral olfactory dysfunction: A systematic review.

96. Prevalence and genetic diversity of Anaplasma and Ehrlichia in ticks and domesticated animals in Suizhou County, Hubei Province, China.

97. The discovery of a novel pyrrolo[2,3-b]pyridine as a selective CDK8 inhibitor offers a new approach against psoriasis.

98. Exploiting BRAF mutations in the therapeutic approach towards oral and maxillofacial tumors.

99. Intermittent blood flow restriction with low-load resistance training for older adults with knee osteoarthritis: a randomized, controlled, non-inferiority trial protocol.

100. Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial.

Catalog

Books, media, physical & digital resources